GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (XBUL:MRK) » Definitions » Cyclically Adjusted PB Ratio

Merck KGaA (XBUL:MRK) Cyclically Adjusted PB Ratio : 2.21 (As of Jul. 05, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Merck KGaA Cyclically Adjusted PB Ratio?

As of today (2025-07-05), Merck KGaA's current share price is лв114.65. Merck KGaA's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was лв51.90. Merck KGaA's Cyclically Adjusted PB Ratio for today is 2.21.

The historical rank and industry rank for Merck KGaA's Cyclically Adjusted PB Ratio or its related term are showing as below:

XBUL:MRK' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.13   Med: 3.51   Max: 6.48
Current: 2.18

During the past years, Merck KGaA's highest Cyclically Adjusted PB Ratio was 6.48. The lowest was 2.13. And the median was 3.51.

XBUL:MRK's Cyclically Adjusted PB Ratio is ranked worse than
53.22% of 746 companies
in the Drug Manufacturers industry
Industry Median: 1.99 vs XBUL:MRK: 2.18

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Merck KGaA's adjusted book value per share data for the three months ended in Mar. 2025 was лв123.162. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is лв51.90 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Merck KGaA Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Merck KGaA's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA Cyclically Adjusted PB Ratio Chart

Merck KGaA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.36 6.38 4.35 3.12 2.76

Merck KGaA Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.44 3.18 3.19 2.76 2.45

Competitive Comparison of Merck KGaA's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Merck KGaA's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merck KGaA's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck KGaA's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Merck KGaA's Cyclically Adjusted PB Ratio falls into.


;
;

Merck KGaA Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Merck KGaA's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=114.65/51.90
=2.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Merck KGaA's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Merck KGaA's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=123.162/127.7792*127.7792
=123.162

Current CPI (Mar. 2025) = 127.7792.

Merck KGaA Quarterly Data

Book Value per Share CPI Adj_Book
201506 59.324 100.417 75.489
201509 59.837 100.417 76.142
201512 53.210 99.717 68.185
201603 53.170 100.017 67.929
201606 54.884 100.717 69.631
201609 55.393 101.017 70.068
201612 56.370 101.217 71.163
201703 58.906 101.417 74.218
201706 58.829 102.117 73.613
201709 62.518 102.717 77.772
201712 63.304 102.617 78.826
201803 66.156 102.917 82.137
201806 66.199 104.017 81.322
201809 68.123 104.718 83.126
201812 74.749 104.217 91.648
201903 76.142 104.217 93.356
201906 75.753 105.718 91.561
201909 76.392 106.018 92.072
201912 75.726 105.818 91.442
202003 78.326 105.718 94.671
202006 77.356 106.618 92.710
202009 80.666 105.818 97.408
202012 78.752 105.518 95.367
202103 86.024 107.518 102.235
202106 88.795 108.486 104.587
202109 92.611 109.435 108.135
202112 92.104 110.384 106.619
202203 96.422 113.968 108.107
202206 104.809 115.760 115.691
202209 106.886 118.818 114.947
202212 104.918 119.345 112.333
202303 106.949 122.402 111.647
202306 110.508 123.140 114.671
202309 115.058 124.195 118.379
202312 111.144 123.773 114.742
202403 116.246 125.038 118.794
202406 117.393 125.882 119.163
202409 120.083 126.198 121.588
202412 119.649 127.041 120.344
202503 123.162 127.779 123.162

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Merck KGaA  (XBUL:MRK) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Merck KGaA Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Merck KGaA's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Merck KGaA Business Description

Industry
Address
Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293
Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The Electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Merck KGaA Headlines

From GuruFocus